Determinants of new product launch success in the Finnish pharmaceutical industry

• In: F9 - Short oral presentations of the FIP Industrial Pharmacy Section on Monday, 1 September 2014, 12:15-13:45
• At: Bangkok (Thailand) (2014)
• Type: Presentation
• By: MATIKAINEN, Minna (University of Helsinki, Faculty of Pharmacy, Helsinki, Finland)
• Co-author(s): Rajalahti, Tarja (The Norwegian Multiple Sclerosis Centre, Bergen, Norway)
  Parvinen, Petri (Aalto University School of Economics, Helsinki, Finland)
  Peltoniemi, Marikki (University of Helsinki, Helsinki, Finland)
  Juppo, Anne (University of Helsinki, Helsinki, Finland)
  
• Abstract:

  A new product launch is a critical, expensive and risky activity. The pharmaceutical industry invests heavily on research and development, experiencing a huge increase in development costs, while the number of approved drugs has declined. Only two out of ten marketed drugs produce revenues matching or exceeding average research and development

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login